These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 153254

  • 1. Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3'-methyl-4-(dimethylamino) azobenzene or diethylnitrosamine.
    Kitagawa T, Sugano H.
    Gan; 1978 Oct; 69(5):679-87. PubMed ID: 153254
    [No Abstract] [Full Text] [Related]

  • 2. Existence of a practical threshold dose for the hepatocarcinogen 3'-methyl-4-(dimethyl-amino) azobenzene in rat liver.
    Hino O, Kitagawa T.
    Gan; 1981 Aug; 72(4):637-8. PubMed ID: 6458530
    [No Abstract] [Full Text] [Related]

  • 3. Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine.
    Shirai T, Hosoda K, Hirose K, Hirose M, Ito N.
    Cancer Lett; 1985 Sep 15; 28(2):127-33. PubMed ID: 2865001
    [Abstract] [Full Text] [Related]

  • 4. Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamine-induced liver carcinogenesis.
    Rabes HM, Szymkowiak R.
    Cancer Res; 1979 Apr 15; 39(4):1298-304. PubMed ID: 154362
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
    Greaves P, Irisarri E, Monro AM.
    J Natl Cancer Inst; 1986 Mar 15; 76(3):475-84. PubMed ID: 2869179
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The natural history of neoplasia. Newer insights into an old problem.
    Pitot HC.
    Am J Pathol; 1977 Nov 15; 89(2):402-11. PubMed ID: 21565
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of inhibition by simultaneously administered phenobarbital of 3'-methyl-4-(dimethylamino)azobenzene-induced hepatocarcinogenesis in the rat.
    Natria T, Watanabe R, Kitagawa T.
    Gan; 1980 Dec 15; 71(6):755-8. PubMed ID: 6791981
    [Abstract] [Full Text] [Related]

  • 10. Persistent changes induced by subcarcinogenic doses of 3'-methyl-4-(dimethylamino)azobenzene in rat liver.
    Ogawa K, Kaneko A, Minase T, Onoé T.
    Gan; 1974 Apr 15; 65(2):109-17. PubMed ID: 4366072
    [No Abstract] [Full Text] [Related]

  • 11. Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methyl-N,N-dimethyl-4-aminoazobenzene in the rat.
    Kitagawa T, Pitot HC, Miller EC, Miller JA.
    Cancer Res; 1979 Jan 15; 39(1):112-5. PubMed ID: 104788
    [Abstract] [Full Text] [Related]

  • 12. [Enzymatic phenotype of preneoplastic islands induced in the rat liver by diethylnitrosamine].
    Estadella MD, Pujol MJ, Domingo J.
    Rev Esp Oncol; 1983 Jan 15; 30(4):491-6. PubMed ID: 6100968
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancing effect of co-administration of polychlorinated biphenyls and diethylnitrosamine on enzyme-altered islands induced by diethylnitrosamine in rat liver.
    Deml E, Oesterle D.
    Carcinogenesis; 1986 Oct 15; 7(10):1697-700. PubMed ID: 2875810
    [Abstract] [Full Text] [Related]

  • 15. Development of cytochrome P-450-altered preneoplastic and neoplastic lesions during nitrosamine-induced hepatocarcinogenesis in the rat.
    Buchmann A, Schwarz M, Schmitt R, Wolf CR, Oesch F, Kunz W.
    Cancer Res; 1987 Jun 01; 47(11):2911-8. PubMed ID: 3567909
    [Abstract] [Full Text] [Related]

  • 16. Correlation between time of partial hepatectomy after a single treatment with diethylnitrosamine and induction of adenosinetriphosphatase-deficient islands in rat liver.
    Ishikawa T, Takayama S, Kitagawa T.
    Cancer Res; 1980 Nov 01; 40(11):4261-4. PubMed ID: 6451284
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Membrane enzyme cytochemical changes in the hepatocytes of diethylnitrosamine induced hepatomas.
    Krustev LP, Mizinska-Boevska YD, Poljakova-Krusteva OT.
    Arch Geschwulstforsch; 1985 Nov 01; 55(2):99-105. PubMed ID: 2988480
    [Abstract] [Full Text] [Related]

  • 19. Quantitative analysis of multiple phenotype enzyme-altered foci in rat hepatocarcinogenesis experiments: the multipath/multistage model.
    Sherman CD, Portier CJ.
    Carcinogenesis; 1995 Oct 01; 16(10):2499-506. PubMed ID: 7586158
    [Abstract] [Full Text] [Related]

  • 20. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
    Cattley RC, Popp JA.
    Cancer Res; 1989 Jun 15; 49(12):3246-51. PubMed ID: 2566380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.